FBLN2 and lung carcinoma: In primary lung cancer tissues, 44.2% (46/104) of tumor samples exhibited negative staining of the Fibulin 2 protein, and SCC samples displayed significantly higher expression of FBLN2 than ADC, indicating its potential diagnostic value for distinguishing lung SCC from ADC.